Essential Exercise for Cancer Patients & Survivors
By: Tina Schmidt-McNulty MS CES RN
Cancer is the second leading cause of death in the United States. It is a very serious diagnosis with a multifaceted approach starting from identification all the way through treatment. Cancer patients are now encouraged to exercise during and after treatment. This course includes important information for health-fitness professionals about cancer and exercise guidelines. Videos guide you through a simple exercise progression for clients with cancer or who are cancer survivors. In the search for a cure, physical activity proves a valuable tool in prevention, treatment, and a progressive return to daily living activities. Learn how to embrace this client base and provide safe and effective programming options.
Current FLS Online members log in to subscribe. 5 Year subscription includes future course revisions.
Successful completion of the quiz is necessary to receive Continuing Education Credit.
Approved for 0.2 Continuing Education Units for the following Certifications
Personal Trainer Certification
New members register to subscribe. 5 Year subscription includes future course revisions.
Course Objectives: After completing this course you will be able to:
Discuss and recognize cancer facts, types, 2 stages, 5 risk factors, and multiple causes.
Recognize how diet and physical activity can play a role in all aspects of cancer.
Discuss 5 treatments used in the cancer process.
Describe the role exercise plays in prevention, progression, and rehabilitation of cancer.
Describe 13 exercise contraindications and 6 special considerations for clients with cancer.
Recognize safe and effective basic exercise guidelines for cardiorespiratory, resistance, and flexibility training for clients with cancer or recovering from cancer.
Describe safe and effective basic resistance training exercises for 5 basic muscle groups with varying levels to be used for clients in various stages of the cancer process and recommendations for flexibility exercises.